Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

ClinicalTrials.gov ID: NCT00005965

Public ClinicalTrials.gov record NCT00005965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Clinical Trial of Bryostatin-1, NSC 339555, and Cisplatin in Patients With Recurrent and/or Advanced Inoperable Squamous Cell, Adeno or Adenosquamous Cell Carcinoma of the Cervix

Study identification

NCT ID: NCT00005965
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Cervical Cancer

Interventions

bryostatin 1 Drug
cisplatin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2000
Primary completion: Not listed
Completion: Mar 31, 2004
Last update posted: Jul 9, 2013

2000 – 2004

United States locations

U.S. sites: 6
U.S. states: 1
U.S. cities: 3

Facility	City	State	ZIP	Site status
Saint Vincent Catholic Medical Center of New York	New York	New York	10011	—
NYU School of Medicine's Kaplan Comprehensive Cancer Center	New York	New York	10016	—
New York Presbyterian Hospital - Cornell Campus	New York	New York	10021	—
Mount Sinai Medical Center, NY	New York	New York	10029	—
Albert Einstein Comprehensive Cancer Center	The Bronx	New York	10461	—
New York Medical College	Valhalla	New York	10595	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00005965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 9, 2013 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005965 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →